No CrossRef data available.
Published online by Cambridge University Press: 01 January 2021
Proposed federal legislation concerning recombinant DNA research attempts to restrict the ability of local governments to regulate the research. In March of 1978, the House Commerce Committee approved a bill that would “bar states and localities from setting their own standards over gene transplant technology.” Two weeks later, the House of Representatives Science, Research, and Technology Subcommittee approved a bill which would permit a state to regulate such researchonly when it is “necessary” to protect local health. The “necessary” standard usually requires strict proof that a regulated substance or activity will cause significant harm to public health. Under this standard a locality might have to wait for significant harm to occur before it could adopt regulations that are stricter than federal requirements.
This anomaly presents the basic question of this article: Who should decide whether recombinant DNA research is a health hazard — the local or the federal government? This article will utilize a legal approach to answer the question, analyzing and weighing the issues presented by pertinent cases.